Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mol Pain. 2007 Dec 17;3:40.

A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition.

Author information

  • 1Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA. mpetrus@gnf.org

Abstract

Mechanical hyperalgesia is a clinically-relevant form of pain sensitization that develops through largely unknown mechanisms. TRPA1, a Transient Receptor Potential ion channel, is a sensor of pungent chemicals that may play a role in acute noxious mechanosensation and cold thermosensation. We have developed a specific small molecule TRPA1 inhibitor (AP18) that can reduce cinnameldehyde-induced nociception in vivo. Interestingly, AP18 is capable of reversing CFA-induced mechanical hyperalgesia in mice. Although TRPA1-deficient mice develop normal CFA-induced hyperalgeisa, AP18 is ineffective in the knockout mice, consistent with an on-target mechanism. Therefore, TRPA1 plays a role in sensitization of nociception, and that compensation in TRPA1-deficient mice masks this requirement.

PMID:
18086313
[PubMed - indexed for MEDLINE]
PMCID:
PMC2222610
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk